New York is currently home to 4600 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including New York, Rochester, Bronx and Buffalo. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
Combined Constraint Therapy and Bimanual Therapy for Children With Unilateral Brain Injury
Recruiting
To examine efficacy of combined unimanual and bimanual intensive therapy in children with unilateral brain injury. A key question in hemiplegia therapy is whether the affected hand should be trained alone or in tandem with the other hand. In constraint-induced movement therapy (CIMT), a participant's less-affected upper extremity is restricted with a sling, cast, or mitt, while the participant actively uses the affected arm and hand in skill-based therapeutic activities. Bimanual therapy, in con... Read More
Gender:
All
Ages:
Between 4 years and 17 years
Trial Updated:
01/05/2022
Locations: Blythedale Children's Hospital, Valhalla, New York
Conditions: Hemiplegia, Cerebral Palsy
The Effect of Auditory Cues on Mood and Gait
Recruiting
The objective of this study is to identify the influence of positive and negative auditory cues, music and a placebo (silence) on mood and gait during 30 minutes of free walking. Participants will be required to walk for a total of 30 minutes with mood being measured every 5 minutes and gait measured throughout the 30 minute protocol.
Gender:
All
Ages:
Between 18 years and 45 years
Trial Updated:
01/04/2022
Locations: Clarkson University, Potsdam, New York
Conditions: Psychological, Auditory Perception
Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging
Recruiting
OptiSkin is now enrolling a new study to monitor nail changes in patients with nail psoriasis treated with Enbrel® (etanercept) with optical coherence tomography (OCT).
Gender:
All
Ages:
18 years and above
Trial Updated:
12/16/2021
Locations: OptiSkin Medical, New York, New York
Conditions: Psoriasis, Psoriatic Arthritis, Psoriatic Nail
COVID-19 Administration of Single-Dose Subcutaneous Anti- Spike(s) SARS-CoV-2 Monoclonal Antibodies Casirivimab and Imdevimab in High-Risk Pediatric Participants Under 12 Years of Age
Recruiting
The primary objective of the study is to characterize the concentrations of casirivimab+imdevimab in serum over time after a single subcutaneous (SC) administration The secondary objectives of the study are: To assess the safety and tolerability of SC or single administration of casirivimab+imdevimab To assess the occurrence of grade ≥3 injection site reactions and grade ≥3 hypersensitivity reactions, in participants treated with SC doses of casirivimab+imdevimab To assess the immunogenicity o... Read More
Gender:
All
Ages:
12 years and below
Trial Updated:
12/06/2021
Locations: Jacobi Medical Center, Bronx, New York
Conditions: COVID-19
A Retrospective Study to Examine the Effect of CMF Stimulation on Primary ACDF Patients
Recruiting
A retrospective parallel group comparison study to support expansion of the indication of the company's FDA approved Spinalogic™ device to include the cervical spine. The SpinalogicTM device was initially approved by FDA as an adjunct to one- or two-level lumbar fusion (P910066/S011). It is a non-invasive bone growth stimulator (BGS) that generates a combined magnetic field (CMF) that has been proven to accelerate bone healing and fusion in the lumbar spine.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
12/06/2021
Locations: BSSNY, White Plains, New York
Conditions: Degeneration of Cervical Intervertebral Disc
Prediction of Outcomes After Surgery for Unruptured Intracranial Aneurysms
Recruiting
Accurate preoperative identification of patients at high risk for adverse outcomes would be clinically advantageous, as it would allow enhanced resource preparation, better surgical decision-making, enhanced patient education and informed consent, and potentially even modification of certain modifiable risk factors. The aim of the Prediction of adverse events after microsurgery for intracranial unruptured aneurysms (PRAEMIUM) study is therefore to develop and externally validate a clinically app... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
12/05/2021
Locations: North Shore University Hospital, Manhasset, New York
Conditions: Aneurysm, Brain
Injection of Autologous Bone Marrow Aspirate in Patients With Degenerative Disc Disease.
Recruiting
Lumbar discectomy and injection of purified cellular bone marrow concentrate or lumbar discectomy only
Gender:
All
Ages:
18 years and above
Trial Updated:
11/22/2021
Locations: New York Presbytarian Hospital, New York, New York
Conditions: Lumbar Disc Disease
The Interactive Physical and Cognitive Exercise System (v3) for Mild Cognitive Impairment (MCI)
Recruiting
The primary purpose of this study is to attempt to replicate and extend promising pilot findings regarding the cognitive benefits of in-home neuro-exergaming with iPACES (interactive Physical and Cognitive Exercise System v3) for persons with mild cognitive impairment (MCI). Participants will include persons with MCI and their co-residing partner who both exercise at home 3-5 times per week for at least 6 months and are followed through one year. All participation is "remote" (completed at home)... Read More
Gender:
All
Ages:
50 years and above
Trial Updated:
11/18/2021
Locations: remote trial conducted via video-conference/mail in-home all locations in the continental USA, Clifton Park, New York
Conditions: MCI, Mild Cognitive Impairment, Alzheimer Disease, Dementia
Early Feasibility Study of the Cardiac Implants Percutaneous Ring Annuloplasty System
Recruiting
An early feasibility study to evaluate the safety and performance of 1) the transcatheter delivery and implantation of the Cardiac Implants (CI) annuloplasty ring and 2) the adjustment of the ring approximately 90 days following implantation in patients suffering from ≥ moderate functional tricuspid regurgitation (FTR).
Gender:
All
Ages:
18 years and above
Trial Updated:
11/18/2021
Locations: Weill Cornell Medicine-New York Presbyterian Hospital, New York, New York
Conditions: Tricuspid Regurgitation Functional
A Phase 1/2, Study of YL-15293 in Subjects With Advanced Solid Tumors With a KRAS G12C Mutation
Recruiting
This is a Phase 1/2, open-label, multicenter study designed to evaluate the maximum tolerated, safety, tolerability and PK of oral YY-15293 in patients with advanced solid tumors with a KRAS G12C mutation, to confirm the recommended phase 2 dose of YY-15293, and to obtain preliminary efficacy information in patients with advanced non-small cell lung cancer (NSCLC) with a KRAS G12C mutation.
Gender:
All
Ages:
18 years and above
Trial Updated:
11/11/2021
Locations: The Tisch Cancer Institute Mount Sinai Health System Icahn School of Medicine at Mount Sinai, New York, New York
Conditions: Advanced Solid Tumor
Reducing Daily Stress Among Sexual and Gender Minorities
Recruiting
The purpose of this study is to identify which mindfulness technique, or combination of mindfulness techniques, is most effective at mediating or eliminating stress in emerging adults who are sexual and gender as well as racial or ethnic minorities. Participants will be randomly assigned to one of eight conditions that are composed of the mindfulness techniques of Awareness, Purpose, and Connection.
Gender:
All
Ages:
Between 18 years and 29 years
Trial Updated:
11/10/2021
Locations: New York University School of Global Public Health, New York, New York
Conditions: Social Discrimination, Sexual and Gender Minorities, Mindfulness
The Effect of Joint Hypermobility Syndrome on Delayed Onset of Muscle Soreness and Recovery Time
Recruiting
The purpose of the study is to investigate Joint Hypermobility Syndrome (JHS) and its effect on delayed onset muscle soreness (DOMS) and recovery time. The hypothesis is that people with JHS will experience increased DOMS when compared to non-hypermobile people. The results this study may assist and add to the body of knowledge when treating and exercising patients with JHS, as considerations can possibly be made when treating this population. Subjects with JHS may experience greater DOMS and re... Read More
Gender:
All
Ages:
Between 18 years and 35 years
Trial Updated:
11/01/2021
Locations: New York Institute of Technology, Old Westbury, New York
Conditions: Hypermobility Syndrome